131 related articles for article (PubMed ID: 9140703)
1. Uremia enhances the blood pressure response to erythropoietin.
Lacasse-M S; Kingma I; Larivière R; Grose JH; Lebel M
Clin Exp Hypertens; 1997 May; 19(4):389-401. PubMed ID: 9140703
[TBL] [Abstract][Full Text] [Related]
2. Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin.
Lebel M; Lacasse-M S; Larivière R; Kingma I; Grose JH
Clin Exp Hypertens; 1998 Nov; 20(8):939-51. PubMed ID: 9817611
[TBL] [Abstract][Full Text] [Related]
3. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
[TBL] [Abstract][Full Text] [Related]
4. Recombinant erythropoietin increases blood pressure in experimental hypertension and uraemia without change in vascular cytosolic calcium.
Roger SD; Fluck RJ; McMahon AC; Raine AE
Nephron; 1996; 73(2):212-8. PubMed ID: 8773347
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA
Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
[TBL] [Abstract][Full Text] [Related]
6. A case of erythropoietin induced hypertension in a bilaterally nephrectomized patient.
Sasaki N; Ando Y; Kusano E; Asano Y
ASAIO J; 2003; 49(1):131-5. PubMed ID: 12558321
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
Brochu E; Lacasse S; Larivière R; Kingma I; Grose JH; Lebel M
J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human erythropoietin (r-HuEPO) therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactin levels in hemodialysis patients.
Yeksan M; Tamer N; Cirit M; Türk S; Akhan G; Akkus I; Erkul I
Int J Artif Organs; 1992 Oct; 15(10):585-9. PubMed ID: 1428205
[TBL] [Abstract][Full Text] [Related]
10. Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.
Brunati C; Cappellini MD; De Feo T; Guastoni C; Ballerini L; Busnach G; Civati G; Fiorelli G; Minetti L
Am J Nephrol; 1992; 12(1-2):9-13. PubMed ID: 1415372
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
[TBL] [Abstract][Full Text] [Related]
12. Effects of uremia and dialysis on brain electrophysiology after recombinant erythropoietin treatment.
Di Paolo B; Di Liberato L; Fiederling B; Catucci G; Bucciarelli S; Paolantonio L; Albertazzi A
ASAIO J; 1992; 38(3):M477-80. PubMed ID: 1457906
[TBL] [Abstract][Full Text] [Related]
13. [A therapeutical approach by administering reduced glutathione to patients with uremic anemia].
Xia N; Qu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):300-2. PubMed ID: 12600115
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
16. Dialyzer urea and creatinine clearances are not significantly altered in erythropoietin treated maintenance hemodialysis patients.
Delano BG; Lundin AP; Galonsky R; Quinn-Cefaro RM; Rao TK; Friedman EA
ASAIO Trans; 1990; 36(1):36-9. PubMed ID: 2306389
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
[TBL] [Abstract][Full Text] [Related]
18. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
20. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
